Final analysis of the multicenter phase II "Bologna 2002" study incorporating thalidomide-dexamethasone (thal-dex) into up-front double autologous stem-cell transplantation (ASCT) for multiple myeloma

ZAMAGNI E;TESTONI N;TERRAGNA C;TACHETTI P;NICCI C;RENZULLI M;TOSI P;FIACCHINI M;PATRIARCA F;DI RAIMONDO, FRANCESCO;CATALANO L;CASULLI A. F;VOLPE S;MASINI L;LEDDA A;BRIOLI A;FALCIONI S;GOZZETTI A;CALIFANO C;PALLOTTI M. C;CELLINI C;CARUBBELLI A;PETRUCCI A;STEFANI P. M;PANTANI L;CECCOLINI M;PERRONE G;BACCARINI M;CAVO M.

2009-01-01